Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors.

about

Bivalent ligand MCC22 potently attenuates nociception in a murine model of sickle cell disease.Accuracy of Patient Opioid Use Reporting at the Time of Medical Cannabis License Renewal.

P2860

Q52316849-5352623B-A1A1-43B5-AA03-F686D2F74658 Q52603583-BEBB1F95-DE79-41EC-8E39-28E8A94B2681

P2860

Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors.

Item

http://www.wikidata.org/entity/Q44342705

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Exploring the first Rimonabant ...... for CB1 and opioid receptors.

@en

Exploring the first Rimonabant ...... for CB1 and opioid receptors.

@nl

type

Item

label

Exploring the first Rimonabant ...... for CB1 and opioid receptors.

@en

Exploring the first Rimonabant ...... for CB1 and opioid receptors.

@nl

prefLabel

Exploring the first Rimonabant ...... for CB1 and opioid receptors.

@en

Exploring the first Rimonabant ...... for CB1 and opioid receptors.

@nl

P1476

Exploring the first Rimonabant ...... for CB1 and opioid receptors.

@en

P2093

Alexandros Patsilinakos

http://www.w3.org/2001/XMLSchema#string

Anna Erdei

http://www.w3.org/2001/XMLSchema#string

Annalisa Chiavaroli

http://www.w3.org/2001/XMLSchema#string

Azzurra Stefanucci

http://www.w3.org/2001/XMLSchema#string

Claudio Ferrante

http://www.w3.org/2001/XMLSchema#string

Csaba Tomboly

http://www.w3.org/2001/XMLSchema#string

Edina Szucs

http://www.w3.org/2001/XMLSchema#string

Ferenc Zador

http://www.w3.org/2001/XMLSchema#string

Giorgia Macedonio

http://www.w3.org/2001/XMLSchema#string

Giustino Orlando

http://www.w3.org/2001/XMLSchema#string

P2860

Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal

AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: implications for opioid/cannabinoid interaction studies

Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors

Inhibitory effects of SR141716A on G-protein activation in rat brain.

Cannabinoids, opioids and eating behavior: the molecular face of hedonism?

Cellular mechanisms underlying the interaction between cannabinoid and opioid system.

Cannabinoid-opioid interactions during neuropathic pain and analgesia.

Pharmacological and biochemical interactions between opioids and cannabinoids.

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.

Modulation of feeding by hypothalamic paraventricular nucleus alpha 1- and alpha 2-adrenergic receptors.

P304

444-451

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14756366.2016.1260565

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28097916

http://www.w3.org/2001/XMLSchema#string

P921

opioid

P932

6009935

http://www.w3.org/2001/XMLSchema#string

Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors.

about

P2860

P2860

Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932